Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft- Versus -Host Disease : Results from Early Access Program in Europe

Blood (2024) 144 (Supplement 1): 4903.

https://doi.org/10.1182/blood-2024-201251

Published: 2024

Journal Articles

Late Hematologic Recovery after CPX-351 Induction Chemotherapy in AML: Predictive Disease and Patient's Factors and Their Impact on Survival

Blood (2023) 142 (Supplement 1): 4275.

https://doi.org/10.1182/blood-2023-182993

Published: 2023

Journal Articles

BCL-2 and BCL-X L Antagonists for the Treatment of Relapsed and Refractory Adult Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. a Campus ALL Real-Life Study

Blood (2022) 140 (Supplement 1): 8979–8980.

https://doi.org/10.1182/blood-2022-163716

Published: 2022

Journal Articles

Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant

Blood (2021) 138 (Supplement 1): 4871.

https://doi.org/10.1182/blood-2021-152907

Published: 2021

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Francesco Saraceni, Myriam Labopin, MD, Edouard Forcade, MD, Nicolaus Kröger, Gerard Socie, MD PhD, Riitta Niittyvuopio, Jan J Cornelissen, MD PhD, Hélène Labussière-Wallet, Didier Blaise, MD PhD, Goda Choi, MD PhD, Jenny Byrne, MD PhD, Gaëlle Guillerm, MD, Thierry Lamy, PhD MD, Jordi Esteve, Ali Bazarbachi, MD PhD, Bipin N. Savani, MD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 2038.

https://doi.org/10.1182/blood-2019-127713

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Francesco Saraceni, Myriam Labopin, MD, Riitta Niittyvuopio, Gerard Socie, MD PhD, Nicolaus Kröger, Edouard Forcade, MD, Paul V Browne, MB,FRCPath, Péter Reményi, Jan J Cornelissen, MD PhD, Stephen Robinson, MBBS, PhD BSc, Ibrahim Yakoub-Agha, MD PhD, Thierry Lamy, PhD MD, Eolia Brissot, MD PhD, Bipin N. Savani, MD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 3327.

https://doi.org/10.1182/blood-2019-127810

Published: 2019

Journal Articles

Thiotepa-Busulfan-Fludarabine in Comparison to Busulfan-Cyclophosphamide As Myeloablative Conditioning Regimen Pre Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Francesco Saraceni, Eric Beohou, Myriam Labopin, MD PhD, William Arcese, MD, Francesca Bonifazi, Polina Stepensky, Mahmoud Aljurf, Benedetto Bruno, Pietro Pioltelli, MD, Jakob R. Passweg, MDMS, Gerard Socie, MD PhD, Stella Santarone, Ibrahim Yakoub-Agha, Bipin N. Savani, MD, Mohamad Mohty, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 4568.

https://doi.org/10.1182/blood.V130.Suppl_1.4568.4568

Published: 2017

Journal Articles

The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib

Elena Marinelli Busilacchi, ScD, Jacopo Olivieri, MD, Nadia Viola, ScD, Antonella Poloni, MD, Giorgia Mancini, MD, Francesco Saraceni, MD, Anna Campanati, MD, Gaia Goteri, MD, Silvia Svegliati, ScD, Armando Gabrielli, MD, Attilio Olivieri, MD

Blood (2016) 128 (22): 4597.

https://doi.org/10.1182/blood.V128.22.4597.4597

Published: 2016

Journal Articles

In Vitro Comparison of Different TKI Activity in T-Cell Populations: Selective Sparing of Treg By Nilotinib

Elena Marinelli Busilacchi, ScD, Andrea Costantini, MD, Nadia Viola, ScD, Benedetta Costantini, MD, Antonella Poloni, MD, Jacopo Olivieri, MD, Francesco Saraceni, MD, Giorgia Mancini, MD, Attilio Olivieri, MD

Blood (2016) 128 (22): 5774.

https://doi.org/10.1182/blood.V128.22.5774.5774

Published: 2016

Journal Articles

Post Induction WT1 MRD Analysis Significantly Predicts Early Relapse in Acute Myeloid Leukemia (AML) Patients

Debora Capelli, MD, Imma Attolico, MD, Giorgia Mancini, MD, Stefania Mancini, Francesco Saraceni, MD, Nadia Viola, Anna Rita Scortechini, MD, Pasquina Pascale, MD, Ilaria Scortechini, MD, Pietro Leoni, Prof, Attilio Olivieri, Prof

Blood (2015) 126 (23): 4976.

https://doi.org/10.1182/blood.V126.23.4976.4976

Published: 2015

Journal Articles

Comparison of Matched/Mismatched Unrelated Donor Stem Cell Transplantation to Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Francesco Saraceni, MD, Myriam Labopin, MD, Norbert Claude Gorin, MD, Didier Blaise, MD PhD, Reza Tabrizi, Liisa Volin, MD PhD, Jan Cornelissen, MD PhD, Jean-Yves Cahn, Patrice Chevallier, MD PhD, Charles Craddock, BM, FRCP, FRCPath, Depei Wu, MD, Anne Huynh, MD, William Arcese, MD, Mohamad Mohty, MD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 3216.

https://doi.org/10.1182/blood.V126.23.3216.3216

Published: 2015

Journal Articles

Incidence, Risk Factors, Treatment and Outcome of Isolated Extramedullary Relapse after Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome

Noga Shem-Tov, MD, Francesco Saraceni, MD, Ivetta Danylesko, MD, Ronit Yerushalmi, MD, Arnon Nagler, MD MSc, Avichai Shimoni, MD

Blood (2015) 126 (23): 4346.

https://doi.org/10.1182/blood.V126.23.4346.4346

Published: 2015

Journal Articles

Geriatric Assessment Driven Treatment In 149 AML Elderly Patients

Debora Capelli, MD, Francesco Saraceni, MD, Martina Chiarucci, MD, Antonella Poloni, Giorgia Mancini, MD, Silvia Trappolini, MD, Massimo Offidani, MD, Serena Rupoli, MD, Mauro Montanari, MD, Anna Rita Scortechini, MD, Guido Gini, MD, Ilaria Scortechini, MD, Giancarlo Discepoli, MD, Pietro Leoni, Prof., Attilio Olivieri, Prof.

Blood (2013) 122 (21): 3943.

https://doi.org/10.1182/blood.V122.21.3943.3943

Published: 2013

Journal Articles

Efficacy and Feasibility of High-Dose Cytarabine Plus Idarubicin and Amifostine As Induction Schedule: A Prospective Observational Study of 100 AML Elderly Fit Patients

Debora Capelli, MD, Martina Chiarucci, MD, Francesco Saraceni, MD, Antonella Poloni, MD, Mauro Montanari, MD, Massimo Offidani, Serena Rupoli, MD, Anna Rita Scortechini, MD, Guido Gini, MD, Ilaria Scortechini, MD, Pietro Leoni, Prof., Attilio Olivieri, Prof.

Blood (2012) 120 (21): 3621.

https://doi.org/10.1182/blood.V120.21.3621.3621

Published: 2012

Journal Articles

Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study

Capelli Debora, Giorgia Mancini, Martina Chiarucci, Francesco Saraceni, Antonella Poloni, MD, Silvia Trappolini, Benedetta Costantini, Mauro Montanari, Guido Gini, Ilaria Scortechini, Pietro Leoni, MD, Attilio Olivieri

Blood (2010) 116 (21): 4357.

https://doi.org/10.1182/blood.V116.21.4357.4357

Published: 2010

NARROW

Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft- Versus -Host Disease : Results from Early Access Program in Europe

Late Hematologic Recovery after CPX-351 Induction Chemotherapy in AML: Predictive Disease and Patient's Factors and Their Impact on Survival

BCL-2 and BCL-X L Antagonists for the Treatment of Relapsed and Refractory Adult Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. a Campus ALL Real-Life Study

Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Thiotepa-Busulfan-Fludarabine in Comparison to Busulfan-Cyclophosphamide As Myeloablative Conditioning Regimen Pre Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib

In Vitro Comparison of Different TKI Activity in T-Cell Populations: Selective Sparing of Treg By Nilotinib

Post Induction WT1 MRD Analysis Significantly Predicts Early Relapse in Acute Myeloid Leukemia (AML) Patients

Comparison of Matched/Mismatched Unrelated Donor Stem Cell Transplantation to Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Incidence, Risk Factors, Treatment and Outcome of Isolated Extramedullary Relapse after Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome

Geriatric Assessment Driven Treatment In 149 AML Elderly Patients

Efficacy and Feasibility of High-Dose Cytarabine Plus Idarubicin and Amifostine As Induction Schedule: A Prospective Observational Study of 100 AML Elderly Fit Patients

Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only